欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1866/001
药品名称octaplasLG
活性成分
    • human plasma proteins 0.0 mg/ml
剂型Solution for infusion
上市许可持有人Octapharma AB Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Austria (AT)
      Octaplas LG 45 - 70 mg/ml Infusionslösung
    • France (FR)
    • Spain (ES)
    • Norway (NO)
    • Poland (PL)
      octaplasLG
    • Latvia (LV)
      Octaplasma šķīdums infūzijām
    • Lithuania (LT)
      octaplasma infuzinis tirpalas
    • Estonia (EE)
      OCTAPLASLG
    • Hungary (HU)
      OCTAPLASLG 45-70 mg/ml oldatos infúzió
    • Bulgaria (BG)
    • Czechia (CZ)
      octaplasLG
    • Romania (RO)
      OctaplasLG 45-70 mg/ml solutie perfuzabila
    • Croatia (HR)
      octaplasLG 45-70 mg/ml otopina za infuziju
    • Malta (MT)
      octaplasLG solution for infusion
    • Slovenia (SI)
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Ireland (IE)
    • Finland (FI)
    • Slovakia (SK)
许可日期2008/04/05
最近更新日期2024/07/02
药物ATC编码
    • B05AA Blood substitutes and plasma protein fractions
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase